Founded by experienced geneticists and bioinformaticians and having facilities in Menlo Park, CA and Cambridge MA, Arc Bio, is structured around development of antimicrobial resistance software - the first in what is intended to be a series of new next-generation sequencing (NGS)-based products addressing pathogen detection. Designated Galileo AMR the antimicrobial resistance (AMR) detection software is designed to provides fast, accurate annotations for any gram-negative bacterial DNA sequence. The firm notes that CDC reports, indicate that annually in the US over 2 million people are infected by antibiotic resistant bacteria with 23,000 reported deaths. Noting that rapid identification of various strains of antimicrobial resistance, and better understanding their transmission and evolution, is vital to protecting public health. Formerly known as MARA and acquired from Spokade a leading company in the field of monitoring and controlling antimicrobial resistance -- Galileo AMR features the most extensive archive of expert-validated gram-negative AMR genes, cassettes and other mobile elements.
